Details for New Drug Application (NDA): 060404
✉ Email this page to a colleague
NDA 060404 describes STREPTOMYCIN SULFATE, which is a drug marketed by Copanos, Lilly, Pfizer, and Xgen Pharms, and is included in six NDAs. It is available from one supplier. Additional details are available on the STREPTOMYCIN SULFATE profile page.
The generic ingredient in STREPTOMYCIN SULFATE is streptomycin sulfate. There are fifteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the streptomycin sulfate profile page.
The generic ingredient in STREPTOMYCIN SULFATE is streptomycin sulfate. There are fifteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the streptomycin sulfate profile page.
Summary for 060404
| Tradename: | STREPTOMYCIN SULFATE |
| Applicant: | Lilly |
| Ingredient: | streptomycin sulfate |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 060404
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 1GM BASE/2ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
